Human colostrum has been used in a number of investigations when preterm human infants cannot, for any reason, breastfeed directly from their mothers. One of the growing fields in these investigations is colostrum therapy, which consists of exposing the oropharyngeal mucosa of these preterm newborns to small amounts of raw colostrum.
Research Aim:
To critically review the scientific evidence about colostrum therapy in premature infants and to explore its influences on the immune system.
Methods:
This systematic review was performed according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA statement). The following databases were searched for potentially eligible studies up to March 10, 2021: Medline, Scopus, Web of Science, Cochrane Library, Embase. Two reviewers independently screened all titles, abstracts, and full texts for eligibility.
Results:
A total of 12 studies with 996 participants were included. A significant difference in lactoferrin levels in the urine was found (SMD 0.70; 95% CI [0.03,1.36]; p = .04; I² = 65% two studies, 112 participants, very low-quality evidence).
Conclusion:
Colostrum seems to result in increasing lactoferrin levels in the urine of premature newborns after 1 week of intervention.
Clinical Trial Registration:
The study was registered at PROSPERO with the number CRD42017073624, submitted on August 9, 2017.
*Abd-ElgawadM.EldeglaH.KhashabaM.NasefN. (2019). Oropharyngeal administration of mother’s milk prior to Gavage feeding in preterm infants: A pilot randomized control trial. Journal of Parenteral and Enteral Nutrition, 44(1), 92–104. https://doi.org/10.1002/jpen.1601
2.
AndreasN. J.KampmannB.Le-DoareK. M. (2015). Human breast milk: A review on its composition and bioactivity. Early Human Development, 91(11), 629–35. https://doi.org/10.1016/j.earlhumdev.2015.08.013
3.
BallardO.MorrowA. L. (2013). Human milk composition: Nutrients and bioactive factors. Pediatric Clinics of North America, 60(1),49–74. https://doi.org/10.1016/j.pcl.2012.10.002
4.
ChawanpaiboonS.VogelJ. P.MollerA. B.LumbiganonP.PetzoldM.HoganD.LandoulsiS.JampathongN.KongwattanakulK.LaopaiboonM.LewisC.RattanakanokchaiS.TengD.N.ThinkhamropJ.WatananirunK.ZhangJ.ZhouW.GülmezogluA. M. (2019). Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis. Lancet Global Health, 7(1), e37–e46. https://doi.org/10.1016/S2214-109X(18)30451-0.
5.
CollinsA.WeitkampJ. H.WynnJ. L. (2018). Why are preterm newborns at increased risk of infection?Archives of Disease in Childhood-Fetal and Neonatal Edition, 103(4), F391–F394. https://doi.org/10.1136/archdischild-2017-313595
6.
Demers-MathieuV.HustonR. K.MarkellA. M.McCulleyE. A.MartinR. L.SpoonerM.DallasD. C. (2019). Differences in maternal immunoglobulins within mother’s own milk and donor human milk and across digestion in preterm infants. Nutrients, 11(4), 920. https://doi.org/10.3390/nu11040920
7.
DinizL. M. O.FigueiredoG. E.CamposB. (2014). O sistema imunológico do recém-nascido [The newborn’s immunological system]. Revista Médica de Minas Gerais [Minas Gerais Medical Journal], 24(2), 233–240. https://doi.org/10.5935/2238-3182.20140056
8.
Di RenzoG. C.Cabero-RouraL.FacchinettiF.HelmerH.HubinontC.JacobssonB.JorgensenJ. S.LamontR. F.MikhailovA.PapantoniouN.RadzinskyV.ShennanA.VilleY.WielgosM.VisserG. H. A. (2017). Preterm labor and birth management: Recommendations from the European Association of Perinatal Medicine. The Journal of Maternal-Fetal & Neonatal Medicine, 30(17), 2011–2030. https://doi.org/10.1080/14767058.2017.1323860
9.
*FerreiraD. M. L. M.OliveiraA. M. M.de LevesD. V.de BemÉ. B.FaturetoG. G.NavarroN. F.AfonsoN. G.SantiagoF. M.MineoJ. R.SopeleteM. C.MartinezF. E.NetoM. B.AbdallahV. O. S. (2019). Randomized controlled trial of oropharyngeal colostrum administration in very-low-birth-weight preterm infants. Journal of Pediatric Gastroenterology Nutrition, 69(1), 126–130. https://doi.org/10.1097/MPG.0000000000002356
10.
*GhaemiS.NavaeiP.RahimiradS.BehjatiM.KelishadiR. (2014) Evaluation of preventive effects of colostrum against neonatal conjunctivitis: A randomized clinical trial. Journal of Education and Health Promotion, 3, 63. https://doi.org/10.4103/2277-9531.134776
11.
*GlassK. M.GreecherC. P.DohenyK. K. (2017). Oropharyngeal administration of colostrum increases salivary secretory IgA levels in very low-birth-weight infants. American Journal of Perinatology, 34(14), 1389–1395. https://doi.org/10.1055/s-0037-1603655
12.
HaschkeF.HaidenN.ThakkarS. K. (2016) Nutritive and bioactive proteins in breastmilk. Annals of Nutrition and Metabolism, 69(2), 16–26. https://doi.org/10.1159/000452820
13.
HigginsJ. P. T.AltmanD. G.GotzscheP. C.JuniP.MoherD.OxmanA. D.SavovicJ.SchulzK. F.WeeksL.SterneJ. A. C., Cochrane Bias Methods Group, & Cochrane Statistical Methods Group (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomized trials. BMJ, 343, d5928. https://doi.org/10.1136/bmj.d5928.
14.
HurleyW. L.TheilP. K. (2011). Perspectives on immunoglobulins in colostrum and milk. Nutrients, 3(4), 442–74. https://doi.org/10.3390/nu3040442
15.
IorioA.SpencerF. A.FalavignaM.AlbaC.LangE.BurnandB.McGinnT.HaydenJ.WilliamsK.SheaB.WolffR.KujpersT.PerelP.VandvikP. O.GlasziouP.SchunemannH.GuyattG. (2015). Use of GRADE for assessment of evidence about prognosis: Rating confidence in estimates of event rates in broad categories of patients. BMJ, 350, h870. https://doi.org/10.1136/bmj.h870
16.
*LeeJ.KimH. S.JungY. H.ChoiK. Y.ShinS. H.KimE. K.ChoiJ. H. (2015). Oropharyngeal colostrum administration in extremely premature infants: An RCT. Pediatrics, 135(2), e357–366. https://doi.org/10.1542/peds.2014-2004
17.
MartinsC. C.RamosM. D. S. X.AmaralM. V. C.CostaJ. S. P.CerqueiraE. S.VieiraT. O.VieiraG. O. (2020). Colostrum oropharyngeal immunotherapy for very low birth weight preterm infants: Protocol of an intervention study. BMC Pediatrics, 20(1),1–11. https://doi.org/10.1186/s12887-020-02266-8.
18.
*Martín-ÁlvarezE.CabanillasJ.VictoriaM.CaballeroM. P.LópezL. S.KajarabilleN.CastroJ. D.HerreraO.JoséJ.LozanoJ. M. (2016). Efectos de la administración de calostro orofaríngeo en recién nacidos prematuros sobre los niveles de inmunoglobulina A [Effects of the administration of oropharyngeal colostrum in preterm infants on immunoglobulin A levels]. Nutrición Hospitalaria [Hospitalary Nutrition], 33(2), 232–238. https://doi.org/10.20960/nh.95
19.
*Martín-ÁlvarezE.Diaz-CastroJ.Peña-CaballeroM.Serrano-LópezL.FernandezJ. M.Sanchez-MartinezB.Martin-PeregrinaF.Alonso-MoyaM.Maldonado-LozanoJ.Hurtado-SuazoJ. A.OchoaJ. J. (2020). Oropharyngeal colostrum positively modulates the inflammatory response in preterm neonates. Nutrients, 12, 1–12. https://doi.org/10.3390/nu12020413
20.
McClellandD. B. L.McGrathJ.SamsonR. R. (1978). Antimicrobial factors in human milk. Studies of concentration and transfer to the infant during the early stages of lactation. Acta Paediatrica Scandinavica, 271, 3–20.
MenchettiL.TrainaG.TomaselloG.Casagrande-ProiettiP.LeonardiL.BarbatoO.BrecchiaG. (2016). Potential benefits of colostrum in gastrointestinal diseases. Frontiers in Bioscience, 8, 331–351. https://doi.org/10.2741/s467
23.
PageM. J.McKenzieJ. E.BossuytP. M.BoutronI.HoffmannT. C.MulrowC. D.ShamseerL.TetzlaffJ. M.AklE. A.BrennanS.E.ChouR.GlanvilleJ.GrimshawJ.M.HrobjartssonA.LaluM.M.LiT.LoderE.W.Mayo-WilsonE.McDonaldS.. . .MoherD. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372,(71). https://doi.org/10.1136/bmj.n71
24.
PammiM.AbramsS. A. (2015). Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD007137.pub4
25.
PanchalH.Athalye-JapeG.PatoleS. (2019). Oropharyngeal colostrum for preterm infants: A systematic review and meta-analysis. Advances in Nutrition, 10(6), 1152–1162. https://doi.org/10.1093/advances/nmz033
26.
RiordanJ.WambachK. (2010). Breastfeeding and human lactation. (4th ed.). Jones and Bartlett Publishers.
27.
*RodriguezN. A.GroerM. W.ZellerJ. M.EngstromJ. L.FoggL.CaplanM. (2011). A randomized controlled trial of the oropharyngeal administration of mother’s colostrum to extremely low birth weight infants in the first days of life. Neonatal Intensive Care, 24(4), 31–35.
28.
RodriguezN. A.MeierP. P.GroerM. W.ZellerJ. M.EngstromJ. L.FoggL. (2010). A pilot study to determine the safety and feasibility of oropharyngeal administration of own mother’s colostrum to extremely low-birth-weight infants. Advances in Neonatal Care, 10, 206–212. https://doi.org/10.1097/ANC.0b013e3181e94133
29.
RodriguezN. A.VentoM.ClaudE. C.WangC. E.CaplanM. S. (2015). Oropharyngeal administration of mother’s colostrum, health outcomes of premature infants: Study protocol for a randomized controlled trial. Trials, 16, 453. https://doi.org/10.1186/s13063-015-0969-6
30.
*Romano-KeelerJ.Azcarate-PerilM. A.WeitkampJ. H.SlaughterJ. C.McdonaldW. H.MengS.LatugaM. S.WynnJ. L. (2017). Oral colostrum priming shortens hospitalization without changing the immune-microbial milieu. Journal of Perinatology, 37(1), 36–41. https://doi.org/10.1038/jp.2016.161
31.
*SohnK.KalanetraK. M.MillsD. A.UnderwoodM. A. (2016). Buccal administration of human colostrum: Impact on the oral microbiota of premature infants. Journal of Perinatology, 36(2), 106–111. https://doi.org/10.1038/jp.2015.157
32.
TomitaM.BellamyW.TakaseM.YamauchiK.WakabayashiH.KawaseK. (1991). Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. Journal of Dairy Science, 74(12), 4137–4142. https://doi.org/10.3168/jds.S0022-0302(91)78608-6.
YangZ. R.SunF.ZhanS. Y. (2017). Risk on bias assessment: Revised Cochrane risk of bias tool for individually randomized, parallel group trials (RoB2. 0). Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 38(9), 1285–1291. https://doi.org/10.3760/cma.j.issn.0254-6450.2017.09.028
36.
*ZhangY.JiF.HuX.CaoY.LatourJ. M. (2017). Oropharyngeal colostrum administration in very low birth weight infants: A randomized controlled trial. Pediatric Critical Care Medicine, 18(9), 869–875. https://doi.org/10.1097/PCC.0000000000001221
37.
*Studies included in this review.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
